Yanhang Gao

Jilin University — China

Medicine · Health Sciences

22h-index2.0kcitations106works3.42yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Liver Disease Diagnosis and Treatment(68), Hepatitis C virus research(43), Hepatitis B Virus Studies(41), Liver Disease and Transplantation(22), Alcohol Consumption and Health Effects(16)

Publications104 total

Response to comment on “A novel model for identifying infections in patients with acute-on-chronic liver disease (AoCLD): a nationwide, multicenter, prospective cohort study”
QJM·2025
Development and validation of an early diagnostic model to distinguish bacterial infection in patients with acute-on-chronic liver disease (AoCLD) and systemic inflammatory response syndrome (SIRS): a post-hoc analysis of a prospective multicenter cohort
Journal of Advanced Research·2025Open Access
Consensus on the Management of Liver Injury Associated with Targeted Drugs and Immune Checkpoint Inhibitors for Hepatocellular Carcinoma (Version 2024)
Journal of Clinical and Translational Hepatology·2025· 1 citedOpen Access
Novel HBV Biomarkers-Guided NAs Withdrawal Strategy Promotes HBsAg Clearance in Asian CHB Patients: A Randomized Controlled Trial
Clinical Gastroenterology and Hepatology·2025
Safety and efficacy of GST-HG141, a novel HBV capsid assembly modulator, for the treatment of chronic hepatitis B patients with low-level viremia: a randomized, double-blind, placebo-controlled, multicenter phase II study
EClinicalMedicine·2025· 1 citedOpen Access
Efficacy and Safety of HSK31679 in Asian Patients With MASLD: A Randomized Controlled Trial
Clinical Gastroenterology and Hepatology·2025
MetALD: new insights and unraveling therapeutic potential
Metabolism and Target Organ Damage·2025Open Access
Novel and simplified model for the precise identification of concurrent bacterial infections in patients aged 60 years and older with acute-on-chronic liver diseases: a nationwide, multicentre, prospective cohort study
Hepatology International·2025· 2 cited
A randomized, phase Ib trial of recombinant human serum albumin in cirrhotic patients with ascites
Hepatology International·2025· 3 citedOpen Access
[Disease burden and future trend predictions of age-related hearing loss in China and worldwide from 1990 to 2021].
PubMed·2025· 1 cited
Serum Creatinine of 1.1 mg/dL Can Indicate Disease Deterioration and 90‐day Mortality in Hospitalized Patients With Cirrhosis in Chinese Population
Portal hypertension & cirrhosis·2025Open Access
OS-075 Dual plasma molecular adsorption system therapy in patients with acute-on-chronic liver failure: a non-randomized clustercontrolled study (PADSTONE)
Journal of Hepatology·2025
LBP-014 HBsAg loss and seroconversion after 16-week or 24-week AHB-137 treatment in HBeAg-negative chronic hepatitis B participants on NA therapy: results from an ongoing multicenter, randomized phase IIb study
Journal of Hepatology·2025· 1 cited
Stressed hepatocyte sustains alcohol-associated hepatitis progression by producing leukocyte cell-derived chemotaxin 2
Gut·2025· 8 cited
Alcohol-Metabolizing Enzymes, Liver Diseases and Cancer
Seminars in Liver Disease·2025· 13 citedOpen Access
Efficacy and safety of GLS4 with entecavir vs entecavir alone in chronic hepatitis B patients: A multicenter clinical trial
Journal of Infection·2025· 3 citedOpen Access
A novel model for identifying infections in patients with AoCLD: a nationwide, multicenter, prospective cohort study
QJM·2025· 4 cited
Nomograms for predicting short-term mortality in acute-on-chronic liver disease caused by the combination of hepatitis B virus and alcohol
Scientific Reports·2024Open Access
Evidence-based incorporation of key parameters into MELD score for acute-on-chronic liver failure
eGastroenterology·2024· 7 citedOpen Access
LBP-045 Efficacy and safety of HSK31679, a thyroid hormone receptor β agonist, for the treatment of asian non-alcoholic fatty liver disease: a multicenter randomized, double-blind, placebo-controlled, phase 2a trial
Journal of Hepatology·2024· 27 cited
page 1 of 6Next →

Frequent Co-authors

Junqi Niu(21), Jia Shang(14), Jinjun Chen(11), Guohong Deng(9), Zhongji Meng(8), Yubao Zheng(8), Bin Gao(7), Hongqin Xu(7), Jidong Jia(7), Xin Zheng(7), Zhiping Qian(7), Xiaobo Lu(7), Yu Shi(7), Yuemin Nan(6), Zhongping Duan(6), Xiaomei Wang(6), Xianbo Wang(6), Beiling Li(6), Huadong Yan(6), Yong He(5)